PharmaDeals Reports - new interactive format
PharmaDeals® publishes a range of reports to help pharmaceutical and biotechnology company strike better deals and understand their competitive landscape. The reports are delivered in electronic and hardcopy formats.
Contact us at email@example.com
- Guide to Valuation of Pharmaceutical Licensing Deals This guide provides essential insight on the issues of most concern to business development and licensing professionals worldwide. It fully addresses concepts in financial modelling and provides detailed valuation examples to minimise the risk in future deals. The report is available in a fully interactive iReports format.
- The Royalty Rate Report: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector This Report is the pharmaceutical and biotech industry’s standard reference work on royalty rates, published annually by IMS PharmaDeals. The 2016 Report presents a dealmakers survey, major new case studies, and provides full, new data and analysis based on data from the PharmaDeals Agreements database, the premier source of deal information, and other sources. The report is also available online is fully interactive. Topics include Royalties and Deal Structures, Sales Milestones, Tiered Royalties, Alternative Structures, Technology Deals, Deal Creativity, Upfront Payments and Milestones, Royalties and IP Values and Market Capitalisation, and Royalty Rates by Phase and Indication.
- Strategies and Tactics for Successful Partnering: A Guide to Partnering Pharmaceutical and Biotechnology Projects Published by PharmaDeals' experts at IMS Health, Strategies and Tactics for Successful Partnering is a practical guide to all aspects of partnering within and between pharmaceutical and biotechnology companies. This report is ideal as a reference to good practice for all dealmakers, as well as invaluable training guide for those new to dealmaking.
- Review of the Dealmaking Performance and Future Strategies of the Top 12 Pharmaceutical Companies PharmaDeals Review of the Dealmaking Performance and Future Strategies of the Top 12 Pharmaceutical Companies compares the top pharma companies according to their M&A and licensing deal activities and helps you understand their strategic intent. Equip your team with business critical information, deal insight and key data on M&A and licensing deal activities of the top 12 pharma companies. The report is based on PharmaDeals Agreements database, which is trusted by the world’s largest pharmaceutical companies.